Xilong Scientific Past Earnings Performance
Past criteria checks 1/6
Xilong Scientific has been growing earnings at an average annual rate of 7.5%, while the Chemicals industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 15% per year. Xilong Scientific's return on equity is 0.6%, and it has net margins of 0.2%.
Key information
7.5%
Earnings growth rate
9.3%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 15.0% |
| Return on equity | 0.6% |
| Net Margin | 0.2% |
| Next Earnings Update | 27 Apr 2024 |
Revenue & Expenses BreakdownBeta
How Xilong Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 7,699 | 16 | 212 | 84 |
| 30 Jun 23 | 7,198 | 17 | 216 | 70 |
| 31 Mar 23 | 6,732 | 6 | 213 | 87 |
| 31 Dec 22 | 6,165 | 75 | 224 | 90 |
| 30 Sep 22 | 4,778 | 119 | 242 | 109 |
| 30 Jun 22 | 4,785 | 126 | 242 | 133 |
| 31 Mar 22 | 5,169 | 252 | 237 | 117 |
| 01 Jan 22 | 5,380 | 187 | 261 | 119 |
| 30 Sep 21 | 6,599 | 170 | 191 | 127 |
| 30 Jun 21 | 6,197 | 163 | 217 | 116 |
| 31 Mar 21 | 6,515 | 78 | 284 | 105 |
| 31 Dec 20 | 6,243 | 57 | 265 | 103 |
| 30 Sep 20 | 5,509 | 59 | 339 | 87 |
| 30 Jun 20 | 4,993 | 49 | 347 | 82 |
| 31 Mar 20 | 3,713 | 51 | 303 | 85 |
| 31 Dec 19 | 3,338 | 39 | 303 | 88 |
| 30 Sep 19 | 3,093 | 17 | 342 | 88 |
| 30 Jun 19 | 3,252 | 39 | 318 | 89 |
| 31 Mar 19 | 3,610 | 44 | 333 | 83 |
| 31 Dec 18 | 3,355 | 71 | 339 | 82 |
| 30 Sep 18 | 3,511 | 103 | 308 | 74 |
| 30 Jun 18 | 3,444 | 101 | 279 | 94 |
| 31 Mar 18 | 3,351 | 93 | 282 | 77 |
| 31 Dec 17 | 3,305 | 90 | 282 | 59 |
| 30 Sep 17 | 3,572 | 77 | 303 | 38 |
| 30 Jun 17 | 3,422 | 77 | 339 | 0 |
| 31 Mar 17 | 3,166 | 87 | 327 | 0 |
| 31 Dec 16 | 2,928 | 97 | 316 | 0 |
| 30 Sep 16 | 2,641 | 100 | 294 | 0 |
| 30 Jun 16 | 2,531 | 98 | 288 | 0 |
| 31 Mar 16 | 2,495 | 94 | 279 | 0 |
| 31 Dec 15 | 2,514 | 91 | 275 | 0 |
| 30 Sep 15 | 2,224 | 92 | 273 | 0 |
| 30 Jun 15 | 2,214 | 84 | 272 | 0 |
| 31 Mar 15 | 2,202 | 76 | 258 | 0 |
| 31 Dec 14 | 2,198 | 78 | 254 | 0 |
| 30 Sep 14 | 2,236 | 69 | 230 | 0 |
| 30 Jun 14 | 2,261 | 61 | 216 | 0 |
| 31 Mar 14 | 2,321 | 53 | 211 | 0 |
| 31 Dec 13 | 2,240 | 49 | 194 | 0 |
| 30 Sep 13 | 2,011 | 50 | 193 | 0 |
| 30 Jun 13 | 1,940 | 58 | 185 | 0 |
Quality Earnings: 002584 has a large one-off gain of CN¥9.8M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: 002584's current net profit margins (0.2%) are lower than last year (2.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002584's earnings have grown by 7.5% per year over the past 5 years.
Accelerating Growth: 002584's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002584 had negative earnings growth (-86.3%) over the past year, making it difficult to compare to the Chemicals industry average (-24.7%).
Return on Equity
High ROE: 002584's Return on Equity (0.6%) is considered low.